LBA26 Phase II study of the oral HIF-2α inhibitor MK-6482 for Von Hippel-Lindau (VHL) disease-associated clear cell renal cell carcinoma (ccRCC): Update on RCC and non-RCC disease
Autor: | Vivek Narayan, Eric Jonasch, W.K. Rathmell, Othon Iliopoulos, Rodolfo F. Perini, Eric Kristopher Park, Sanjay Thamake, Frede Donskov, Tobias Else, Benjamin L. Maughan, R. Srinivasan, Sarah J. Welsh, Stéphane Oudard, Jodi K. Maranchie, W.M. Linehan |
---|---|
Rok vydání: | 2020 |
Předmět: | |
Zdroj: | Annals of Oncology. 31:S1158 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |